GLOW (BPC-157 10mg + TB-500 5mg + GHK-Cu 35mg)

$89.00

RESEARCH USE ONLY

10 in stock (can be backordered)

1 Vial
$185.00 Per Vial
$185.00
2 Vials
$175.75 Per Vial (SAVE 5% Per Vial)
$351.50
$370.00
3 Vials
$166.50 Per Vial (SAVE 10% Per Vial)
$499.50
$555.00
4 Vials
$157.25 Per Vial (SAVE 15% Per Vial)
$629.00
$740.00
5 Vials
$148.00 Per Vial (SAVE 20% Per Vial)
$740.00
$925.00
6 Vials
$138.75 Per Vial (SAVE 25% Per Vial)
$832.50
$1,110.00
7 Vials
$129.50 Per Vial (SAVE 30% Per Vial)
$906.50
$1,295.00
8 Vials
$120.25 Per Vial (SAVE 35% Per Vial)
$962.00
$1,480.00
9 Vials
$111.00 Per Vial (SAVE 40% Per Vial)
$999.00
$1,665.00
10 Vials
$101.75 Per Vial (SAVE 45% Per Vial)
$1,017.50
$1,850.00
Category:

Description

GLOW is a three-peptide research blend combining GHK-Cu, BPC-157 and TB-500. It is primarily associated with skin remodelling, connective-tissue research, wound healing, and regenerative pathways.

The combination is a community-created formulation rather than a single molecule.

Product Information

GHK-Cu is a copper-binding tripeptide associated with extracellular matrix remodelling. BPC-157 is investigated mainly in tissue-repair models, while TB-500 is related to thymosin-beta-4 signalling.

Current research supports the individual peptides much more strongly than the blend itself.

How Does It Work?

The blend combines GHK-Cu’s matrix-remodeling pathways with BPC-157 and TB-500 tissue-repair signalling.

Benefits

Skin and Collagen Research

GHK-Cu is extensively studied in relation to collagen production, extracellular matrix remodelling, and skin repair, making it the primary cosmetic-research component.

Tissue-Repair Research

BPC-157 research has focused on tendon, ligament, muscle and gastrointestinal tissue models, while TB-500-related research focuses on cell migration and wound closure.

Wound-Healing Research

The three peptides converge on several repair-related pathways, including cell migration, angiogenesis, and extracellular matrix remodelling.

Regenerative Research

The blend’s popularity comes from combining three different research pathways rather than relying on one peptide. However, no controlled clinical trial has established that GLOW itself produces synergistic effects.